About Chad Deal, MD
Chad Deal, MD is Head, Center for Osteoporosis and Metabolic Bone Disease at the Cleveland Clinic. He is a board-certified rheumatologist with specialty interests in osteoporosis and related conditions.
Dr. Deal did his undergraduate work at Washington University, St. Louis, MO. He attended medical school at the University of Arkansas, graduating in 1977. His internship and residency were at Boston City Hospital in Boston, MA. He completed a fellowship in arthritis and connective tissue diseases at Boston University School of Medicine in 1982.
Dr. Deal has been in Cleveland since 1984. He was Associate Professor of Medicine at the Case Western Reserve University School of Medicine until 1999 when he left to become head of the Section of Osteoporosis and Metabolic Bone Disease at The Cleveland Clinic Foundation.
Dr. Deal has been an active investigator in multiple clinical trials relating to arthritis and osteoporosis. He has been an investigator in multicenter studies related to steroid-induced osteoporosis and Miacalcin, hip fractures and risedronate, and the multiple outcomes of raloxifene evaluation (MORE trial).
Dr. Deal is a practicing rheumatologist at the Cleveland Clinic in Cleveland, OH.
SpineUniverse, a Vertical Health, LLC website, is committed to ensuring that the medical information it presents is accurate, balanced, objective, and trustworthy.
To help achieve this goal, SpineUniverse requires all authors, editors, and reviewers to disclose any financial relationships or affiliations they have with companies whose products or services may be mentioned in the content they author, edit, or review.
The intent of this policy is to identify any perceived, potential, or real conflicts of interest so that readers can make their own judgments about the value of information being presented.